Evrópusambandið - íslenska - EMA (European Medicines Agency)

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - Öll önnur lækningavörur - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter holding b.v.* - sodium hydrogen carbonate; sodium chloride; calcium chloride; magnesii chloridum; acidum lacticum - blóðskilunar-/blóðsíunarlausn

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter holding b.v.* - sodium citrate; sodium chloride - blóðsíunarlausn - 18/140 mmól/l

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - sodium chloride; kalii chloridum; magnesii chloridum; sodium acetate trihydrate; natrii gluconas - innrennslislyf, lausn

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter holding b.v.* - calcium chloride; magnesii chloridum; sodium chloride; sodium hydrogen carbonate; kalii chloridum; disodium phosphate dodecahydrate - blóðskilunar-/blóðsíunarlausn - 1,2 mmol/l

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

norgine healthcare b.v. - macrogol 3350; sodium hydrogen carbonate; kalii chloridum; sodium chloride - mixtúruduft, lausn - 6,9 g

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

norgine healthcare b.v. - macrogol 3350; sodium chloride; sodium hydrogen carbonate; kalii chloridum - mixtúruduft, lausn - 13,8 g

Evrópusambandið - íslenska - EMA (European Medicines Agency)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - Æxlishemjandi lyf - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

n.v. organon - alendronic sýru, colecalciferol - beinþynning, eftir tíðahvörf - lyf til að meðhöndla beinsjúkdóma - meðferð við beinþynningu eftir tíðahvörf hjá sjúklingum í hættu á d-vítamínskorti. vantavo dregur úr hættu hryggjarliðum og mjöðm beinbrot. meðferð tíðahvörf beinbrot í sjúklingum sem eru ekki fá vítamín-d viðbót og eru í hættu á d-d lungnastarfsemi. vantavo dregur úr hættu hryggjarliðum og mjöðm beinbrot.